Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 23Unknown 11Active not recruiting 8Terminated 3Not yet recruiting 3Withdrawn 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Recurrence 1Lymphoma, B-Cell 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 21fludarabine 17Specimen Handling 13Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 9Radiotherapy 7Cisplatin 7fludarabine phosphate 5Injections 5tislelizumab 4daratumumab 4Rituximab 4Paclitaxel 4Ipilimumab 4Interleukin-2 4Immune Checkpoint Inhibitors 4Gemcitabine 4Fluorouracil 4Drug Therapy 4Doxorubicin 4Dexamethasone 4Carboplatin 4Biopsy 4venetoclax 3toripalimab 3X-Rays 3Radiosurgery 3Platinum 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Immunotherapy, Adoptive × Clear all
NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Shanghai Tongji Hospital, Tongji University School of Medicine

Phase 1 Not yet recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

NCT07032324 2025-06-23

CT1190B

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Not yet recruiting
27 enrolled
Lymphoid

Lymphoma, B-Cell

NCT06647329 2024-10-17

CAR-T Therapy

Zhengzhou University

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡